small cryptocurrency, Block

Bank of America Securities lowered the Adobe target price from $640.00 to $605.00.Enterprise IT Expenditure Survey: Google Cloud is expected to be the first choice for 50% of the respondents. Tae Kim, a science and technology columnist, wrote that according to a recent survey, Google Cloud has risen rapidly in the enterprise AI expenditure competition and may become the winner. According to the 2025 CIO survey released by Piper Sandler, 81 CIOs were asked about their budget priorities in different suppliers and technical fields. According to the survey, 87% of CIOs surveyed expect to increase the IT budget in 2025, which is the highest proportion of the survey since 2020. In this survey, the status of Google Cloud has risen significantly, surpassing Microsoft and OpenAI to become the "most strategic" AI supplier, with a support rate of 27%, a significant increase from 15% six months ago. Relatively speaking, Microsoft's support rate dropped from 33% to 24%. When asked which cloud company they plan to use to test or implement AI projects next year, 50% of the respondents chose Google Cloud, making it the top AI infrastructure provider. In addition, Harsh Kumar, a Piper semiconductor analyst, pointed out that these results are also beneficial to Invista, because all cloud companies are the main buyers of AI chips in NVIDIA. Kumar estimates that the entire AI chip market will have more than $500 billion in business opportunities by 2028.Russia's central bank's gold and foreign exchange reserves reached US$ 614.4 billion in the week of December 6, with the previous value of US$ 614.1 billion.

In the direction of pan-consumption, there were more than 50 stocks with daily limit, and the concept of big consumption continued to strengthen. Retail, food, home, ice and snow industries and other branches set off a wave of daily limit, and Zhongbai Group, Youhao Group, Huifa Food, Panda Dairy, Wole Home and Meike Home exceeded 50 stocks with daily limit.Dongyang Guangyao submitted a prospectus to be listed in Hong Kong by way of introduction. On December 11th, Dongyangguang Pharmaceutical, the controlling shareholder of Dongyangguang Changjiang Pharmaceutical, submitted a prospectus to the Hong Kong Stock Exchange to be listed in Hong Kong by way of introduction, and the exclusive sponsor was CICC.The average annual salary of doctors is 690,000, and the fixed income accounts for 70%. On the afternoon of December 10th, National Health Commission held a press conference in Shenzhen around the promotion of Sanming's medical reform experience. Relevant officials in Guangdong, Guangzhou and Shenzhen introduced the local medical reform including centralized procurement, price adjustment and salary reform. In 2012, the Shenzhen Municipal People's Government fully invested in introducing the modern management mode of the University of Hong Kong and established the Shenzhen Hospital of the University of Hong Kong. From the details of space design and department name, we can feel that this hospital is different from ordinary mainland hospitals, and the difference in internal system may be even greater-the average annual salary of doctors in this hospital is 690,000 yuan, which is 4.8 times that of the local social wage, of which the fixed salary accounts for 70% and the performance appraisal is 30%. Generally speaking, performance income accounts for a large part of doctors' income. The reporter interviewed two doctors in tertiary hospitals in Beijing, and their performance pay accounted for about 60-70%, which was significantly higher than the fixed salary. In a set of internal data presented by Xu Xiaoping, secretary of the Party Committee of Shenzhen Hospital of the University of Hong Kong, the salary structure of three well-known 3A hospitals in Beijing, Sichuan and Zhejiang is listed, showing that the proportion of fixed income ranges from 20% to 47%. (Beijing News)

Huadong Pharmaceutical has established a new company in Jiaxing with a registered capital of 60 million yuan. According to Tianyancha App, Huadong Pharmaceutical (Jiaxing) Co., Ltd. was recently established with Zhu Li as its legal representative and a registered capital of 60 million yuan. Its business scope includes drug wholesale, drug retail, decoction service for Chinese herbal pieces, third-class medical device operation, drug Internet information service, drug import and export, third-class medical device rental and medical device Internet information service. According to shareholder information, the company is wholly owned by Huadong Pharmaceutical (000963).The turnover of Shanghai, Shenzhen and Beijing exceeded 1.5 trillion yuan, 52.2 billion yuan more than the previous day. Up to now, the turnover of Shanghai, Shenzhen and Beijing exceeded 1.5 trillion yuan, 52.2 billion yuan more than the previous day. Among them, the turnover of Shanghai Stock Exchange was 584.4 billion yuan, that of Shenzhen Stock Exchange was 899.8 billion yuan, and that of Beizheng 50 was 15.8 billion yuan.Xinxuan Group: The sales volume of the "Xin Huo Plan" is nearly 2 billion yuan, and Xinxuan Group disclosed the sales data of the live broadcast of the "Xin Huo Plan" in Shanxi Station. Statistics show that the two live broadcasts brought a total of 3.67 million orders, helping Shanxi specialty products with sales exceeding 180 million yuan to go nationwide. It is understood that this activity is guided by the Shanxi Provincial Department of Commerce. According to the disclosure, Xinxuan Group's "Xin Huo Plan" went to the whole country to carry out a number of live broadcast activities to help farmers, with sales of nearly 2 billion yuan. In addition, Xinxuan Group has donated a total of nearly 400 million yuan to the society. (Sina Technology)